| The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Y Ebina, L Ellis, K Jarnagin, M Edery, L Graf, E Clauser, J Ou, F Masiarz, ... Cell 40 (4), 747, 1985 | 1827 | 1985 |
| Expression cloning of a rat B2 bradykinin receptor AE McEachern, ER Shelton, S Bhakta, R Obernolte, C Bach, P Zuppan, ... Proceedings of the National Academy of Sciences 88 (17), 7724-7728, 1991 | 538 | 1991 |
| Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle T Mirzadegan, F Diehl, B Ebi, S Bhakta, I Polsky, D McCarley, M Mulkins, ... Journal of Biological Chemistry 275 (33), 25562-25571, 2000 | 326 | 2000 |
| Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action B Ganter, S Tugendreich, CI Pearson, E Ayanoglu, S Baumhueter, ... Journal of biotechnology 119 (3), 219-244, 2005 | 325 | 2005 |
| Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B CD Paavola, S Hemmerich, D Grunberger, I Polsky, A Bloom, ... Journal of Biological Chemistry 273 (50), 33157-33165, 1998 | 263 | 1998 |
| Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2 S Hemmerich, C Paavola, A Bloom, S Bhakta, R Freedman, D Grunberger, ... Biochemistry 38 (40), 13013-13025, 1999 | 226 | 1999 |
| Classification of a large microarray data set: algorithm comparison and analysis of drug signatures G Natsoulis, L El Ghaoui, GRG Lanckriet, AM Tolley, F Leroy, S Dunlea, ... Genome Research 15 (5), 724-736, 2005 | 150 | 2005 |
| Novel inhibitors of poly (ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast E Perkins, D Sun, A Nguyen, S Tulac, M Francesco, H Tavana, H Nguyen, ... Cancer research 61 (10), 4175-4183, 2001 | 149 | 2001 |
| Identification of surface residues of the monocyte chemotactic protein 1 that affect signaling through the receptor CCR2 K Jarnagin, D Grunberger, M Mulkins, B Wong, S Hemmerich, C Paavola, ... Biochemistry 38 (49), 16167-16177, 1999 | 148 | 1999 |
| A gene expression signature that predicts the future onset of drug-induced renal tubular toxicity MR Fielden, BP Eynon, G Natsoulis, K Jarnagin, D Banas, KL Kolaja Toxicologic pathology 33 (6), 675-683, 2005 | 129 | 2005 |
| Probing for the bradykinin B2 receptor in rat kidney by anti-peptide and anti-ligand antibodies. CD Figueroa, CB Gonzalez, S Grigoriev, SAA Alla, M Haasemann, ... Journal of Histochemistry & Cytochemistry 43 (2), 137-148, 1995 | 129 | 1995 |
| Extracellular domains of the bradykinin B2 receptor involved in ligand binding and agonist sensing defined by anti-peptide antibodies SA Alla, U Quitterer, S Grigoriev, A Maidhof, M Haasemann, K Jarnagin, ... Journal of Biological Chemistry 271 (3), 1748-1755, 1996 | 128 | 1996 |
| The cDNA of a human lymphocyte cyclic-AMP phosphodiesterase (PDE IV) reveals a multigene family R Obernolte, S Bhakta, R Alvarez, C Bach, P Zuppan, M Mulleins, ... Gene 129 (2), 239-247, 1993 | 124 | 1993 |
| Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system African trypanosomiasis B Nare, S Wring, C Bacchi, B Beaudet, T Bowling, R Brun, D Chen, ... Antimicrobial agents and chemotherapy 54 (10), 4379-4388, 2010 | 117 | 2010 |
| Boron-based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center YR Freund, T Akama, MRK Alley, J Antunes, C Dong, K Jarnagin, ... FEBS letters, 2012 | 106 | 2012 |
| Applications of toxicogenomic technologies to predictive toxicology and risk assessment National Research Council, Division on Earth, Life Studies, ... National Academies Press, 2007 | 103 | 2007 |
| Fed-batch culture of insect cells: a method to increase the yield of recombinant human nerve growth factor (rhNGF) in the baculovirus expression system B Nguyen, K Jarnagin, S Williams, H Chan, J Barnett Journal of biotechnology 31 (2), 205-217, 1993 | 97 | 1993 |
| Purification and characterization of the receptor for insulin-like growth factor I DO Morgan, K Jarnagin, RA Roth Biochemistry 25 (19), 5560-5564, 1986 | 96 | 1986 |
| The liver pharmacological and xenobiotic gene response repertoire G Natsoulis, CI Pearson, J Gollub, B P Eynon, J Ferng, R Nair, R Idury, ... Molecular systems biology 4 (1), 175, 2008 | 94 | 2008 |
| Treatment of skin inflammation with benzoxaborole phosphodiesterase inhibitors: selectivity, cellular activity, and effect on cytokines associated with skin inflammation and … C Dong, C Virtucio, O Zemska, G Baltazar, Y Zhou, D Baia, ... Journal of Pharmacology and Experimental Therapeutics 358 (3), 413-422, 2016 | 85 | 2016 |
Kyle KolajaCelgeneVerified email at celgene.com
